2014 Participating Investors

  • Recommend
  • Tweet
  • Print
  • Email

Below are the investors in attendance at the 2014 BIO CEO & Investors Conference. 

203 Investment Partners
21st Century Investors
Aceras Biomedical
Aceras Partners LLC
ACT Capital Management
Actin Biomed
Advent Healthcare Ventures
Aegis Capital Corp.
Aisling Capital LLC
Akana Healthcare Capital
Akemi Capital
Alger Management, Inc.
Alliance Bernstein
Almorli Capital
Altrinsic Global Advisors
AM Pappas & Associates
American Capital
American Portfolio Advisors
Amici Capital
AmTrust Financial
Anson Group Canada
Apache Capital Management
Aperture Venture Partners
Arcus Ventures
Ardana Capital
Arjava Capital Group
Array Capital Management, LLC
Arthritis Foundation
Ascendiant Capital Markets LLC
Aspire Capital Partners
ATEL Ventures
Athyrium Capital Management
Athyrium Opportunities Advisors LLC
Atika Capital Management, LLC
Atlantis Investment
Atlas Capital
Auriga Capital Management
Auxol Capital LLC
Avet Capital Management
Avior Capital
AZCA Venture Partners
Bain Capital
Bank of America Merrill Lynch
Bayshore venture
BDC Healthcare Fund
Bergmor Capital
Bienville Capital
Bijan Capital
Bill and Melinda Gates Foundation
BioMaryland Center
BioMed Ventures
Biotech Stock Review
Bishop Capital Management
Black Diamond
Bloom Burton & Co.
Blue Arrow Capital Management, LLC
Bluelane Capital
BMNova llc
BNY Mellon
Boodell & Co
Brean Capital
Brightline Capital Management, LLC
Brill Securities, Inc.
Brinson Patrick Securities Corporation
Burrage Capital
Burrill & Company
BVF Partners
Cabilly Investment
Cantor Fitzgerald
Capital Royalty
Cato BioVentures
Caxton Alternative Management LP
Cedarlane Enterprises inc
Cedrus Investments
Chardan Capital Market
Chelsea Financial Services
China Private Equity Group, 
Colt Ventures
Columbus Circle Investors
Connectis Ventures
Cortina Asset Management
Cowen and Company
Crede Capital Group
Critical Mass Partners
Cross Current Research LLC
Crown Point Group
Dabar Investment Associates
Dalek Capital Management, LLC
Deca Ventures, LLC
Deerfield Management
Delwar Capital
Destrier Capital Management
DLS Research
Douglas C. Lane & Associates, Inc
DR Associates
DSM Capital Partners
Eachwin Capital LP
Early Harvest Fund
Easton Capital Investment Group
EcoR1 Capital
Eddystone Capital LLC
Edgewood Management LLC
Edison Investment Research
EGB Advisors, LLC
Emerald Advisers, Inc.
Emerging Growth Equities
Empire Asset Management
Ennovance Capital 
Enso Ventures
Essex Investment Management Company, LLC
Essex Woodlands Health Ventures
F.B.Asset Management
Favus Institutional Research LLC
FC Capital Management 
Federated Kaufmann Fund 
Fidelity Biosciences
FireRock Capital
First Island Capital
First Manhattan Co.
Five Corners Capital Inc.
FMB Research
Foresite Capital
Fountain Healthcare Partners
Gabelli & Company
Gagnon Securities
GE Capital, Life Science Finance
Gem Partners
General American Investors
Global Corporate Finance
Global Energy Capital LLC
Goldman Sachs
Granite Point Capital
Green Owl Capital Management
Greenwich LifeSciences
Greywall Asset Management
Griffin Securities
H.C. Wainwright & Co.
Halcyon Cabot Partner, LLC
HBM Partners
HealthCor Management
Hercules Technology Growth Capital, Inc.
HI Investors Capital
HK & Associates
Horizon Technology Finance
Hutchin Hill Capital
Iguana Healthcare
Iliad Ventures LLC
Integra LifeSciences
Intrinsic Value Capital
Ironridge Global Partners, LLC
IS Ceske Sporitelny
J. Goldman & Co. 
J.P. Morgan
Jarislowsky Fraser Ltd
Jennison Associates
Jina Ventures Inc.
JMP Securities
Johnston Associates
JP Morgan
Kalex Capital, LLC
Kareg Research/Double U Fund
Karthala Asset Management
Katz Associates
Kingdon Capital Management, LLC
Knoll Capital Management, LLC
Knott Partners, LP
Korea-Seoul Life Science Fund (KSLSF)
Ladenburg Thalmann & Co. Inc.
Laidlaw & Company
Landmark Angels, Inc.
Lexington Capital Management
LF Advisors LLC
LFP Capital
Life Science Ventures
LifeSci Advisors
LifeScience EquityPartners, LLC
LifeTech Capital
Lincoln Park Capital 
Little Gem Life Sciences
Livingston Securities
Loeb King Capital Management
Loeb Partners
Logical Ventures
Lombard Odier Asset Management
Loncar Family
Long Wharf Investors, Inc.
Magna Group Capital
Markston International LLC
Maryland Dept. of Bus.& Economic Devlpmnt/Maryland Venture Fund
Maxim Group, LLC
Maz Capital Advisors
Mazama Capital
Medimmune Ventures, Inc.
MedPro Investors LLC
Mehta Partners
Mercadyne Investments, LLC
Merlin Nexus
MFP Investors
Mid Atlantic Bio Angels
Midfarm Capital LLC
Mitchell & Sullivan Capital 
Mitsui Global Investment
Mizuho Securities
MLV & Co.
Monness Crespi Hardt
Morgan Stanley 
Mountain Brook Capital Management LLC
MP Healthcare Venture Management, Inc.
MSF Capital Advisors
Muse Capital LLP
MVP Capital Partners
Needham & Company
New Enterprise Associates
New Leaf Venture Partners
NGN Capital
NJ Investment Division
Nordcon Capital
Norumbega Capital
Novo Ventures US Inc.
Nowak Ventures LLC
Numoda Capital Innovations
Oak Ridge Investments LLC
On-Point Capital, LLC
Opaleye Management
Oppenheimer & Co. Inc.
Opus Point Partners
Oracle Investment Management, Inc.
OrbiMed Advisors
Oxford Finance LLC
Pacific Rim Ventures
Palkon Capital Management
Pappas Ventures
Perceptive Advisors
Peregrine Capital Management
Pioneer Investments
Piper Jaffray
Profit Investments
ProMed Partners
ProQuest Investments
Prospector Partners
Quogue Capital
QVT Financial
R.F. Lafferty
Revach Fund LP
Rho Ventures
Ridgeback Capital Management, LLC
Robert W. Baird
Rockefeller & Co.
Rocker Funder
Rolin Inc.
Roosevelt Investments
ROTH Capital Partners
Roy Healthcare Research
Royalty Pharma
RTW Investments
RusBio Ventures
RW Baird
S&P Capital IQ
Sabby Management
SAC Capital
Samsung Life Investment America, Ltd.
Samtheo Biopharma LLC
Sands Capital
Sapidus Investment Advisors
Schroders Investment Management
Seaside88, LP
Sectoral asset Management
Serrado Capital
Shaw Strategic Capital
Sio Capital Management
Slater Technology Fund
SLC Management
Small Business Technology Investment Fund
Somerset Capital Group, Ltd.
Sophrosyne Capital
Soros Fund Management LLC
Spencer Edwards Investment
Sphera Global Healthcare Fund
SR One
Stadnyk and Partners
Stanphyl Capital
Strategy Signal LLC
Stuyvesant Capital Management
Summer Street Research
Sunrise Equity Partners
SunTrust Robinson Humphrey
Symmetry Capital
Symphony Capital LLC
Syzygy Therapeutics
TaiAn Technologies
Taiho Pharmaceutcal Co., Ltd. 
Target Health Inc 
Technological & Investment Horizons
Tecumseh Partners
Tegris Advisors
The Astrologers Fund
The Channel Group, LLC
The Issaquena Trust
The Keiser Foundation
The Lind Partners
Thomas, McNerney & Partners
Thompson Biotechnology Group
TIAA-CREF Investment Management
Tripoint Global Equities
US Steel Pension Fund
V2M Capital 
Valquest Capital Management
Vanguard Group
VAO Partmers
Var2 Pharmaceuticals
Vector International
Veziris Ventures LLC
Vinart Corp Capital Management
Visium Asset Management 
Watervein Partners, Inc.
WBB Securities LLC
Weiss Multi-Strategy Advisers
Wexford Capital LP
Wingate Capital Management Inc.
WK Mahon & Co.
Wolf Capital Management
Wood Creek Capital Management, LLC
World Tech Ventures, LLC
Yorkville Advisors
Young Capital Partners


*As of 2/4/2014